Patent details

Basic Information

Publication number:

EP2906248

PCT Application Number:

EP2013071235

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP137800991

PCT Publication Number:

WO2014057073

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF

French Title of Invention:

PYRROLOBENZODIAZÉPINES ET LEURS CONJUGUÉS

German Title of Invention:

PYRROLOBENZODIAZEPINE UND KONJUGATE DAVON

SPC Number:

Dates

Filing date:

11/10/2013

Grant date:

05/12/2018

EP Publication Date:

19/08/2015

PCT Publication Date:

17/04/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/12/2018

EP B1 Publication Date:

05/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/10/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/11/2018

 

 

Name:

MedImmune Limited

Address:

Milstein Building Granta Park, Cambridge CB21 6GH, United Kingdom (GB)

Inventor

Name:

HOWARD, Philip Wilson

Address:

United Kingdom (GB)

Priority

Priority Number:

201261712924 P

Priority Date:

12/10/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61P 35/00; A61P 39/00; C07D 487/04; C07D 519/00; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

201849

Publication date:

05/12/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/10/2025

Annual Fee Number:

13

Annual Fee Amount:

180 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/09/2024

Last Annual Fee Paid Number:

12

Last Annual Fee Paid Amount:

165 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages